← Back
$UTHR All transactions

UNITED THERAPEUTICS Corp

▼ SELL 10b5-1 Plan

$ Value

$140K

Shares

506

Price

$276

Filed

Jun 16

Insider

Name

MAHON PAUL A

Title

EVP & GENERAL COUNSEL

CIK

0001231589

Roles

Officer

Transaction Details

Transaction Date

2025-06-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

47,275

Footnotes

This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. | This transaction was executed in multiple trades at prices ranging from $275.52 to $276.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $276.62 to $277.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $278.05 to $279.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $279.06 to $280.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $280.07 USD to $281.04 USD; the price reported above reflects the weighted average sale price. | This transaction was executed in multiple trades at prices ranging from $281.14 to $282.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $282.25 to $282.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001562180-25-004834

Form Type

4

Issuer CIK

0001082554

MAHON PAUL A's History

Date Ticker Type Value
2026-04-16 UTHR M $1.2M
2026-04-16 UTHR $115K
2026-04-16 UTHR $944K
2026-04-16 UTHR $1.0M
2026-04-16 UTHR $1.9M
2026-04-16 UTHR $748K
2026-04-16 UTHR M $0
2026-04-02 UTHR M $1.2M
2026-04-02 UTHR $288K
2026-04-02 UTHR $197K

Other Insiders at UTHR (90d)

Insider Bought Sold Last
ROTHBLATT MARTINE A
Chairperson & CEO
$193.8M 2026-04-22
KURZWEIL RAY $2.4M 2026-03-04
PATUSKY CHRISTOPHER $579K 2026-04-17
MAHON PAUL A
EVP & GENERAL COUNSEL
$25.9M 2026-04-16
CAUSEY CHRISTOPHER $1.3M 2026-03-30
Thompson Tommy G $2.1M 2026-03-26
Olian Judy D. $417K 2026-03-23
EDGEMOND JAMES
CFO AND TREASURER
$50.8M 2026-04-20
BENKOWITZ MICHAEL
PRESIDENT AND COO
$60.0M 2026-03-15
MALCOLM JAN $97K 2026-03-17